Accumulating evidence indicates that ‘presymptomatic’ activation of inflammatory pathways is a common feature of other, later-onset forms of muscular dystrophy as well, including those caused by deficiencies in dysferlin or dystrophin [12], [13]. The gene discussed is DYSF; the disease is muscular dystrophy.